Results 11 to 20 of about 166,918 (340)
Epidemiologic trends of and factors associated with overall survival in patients with neuroendocrine tumors over the last two decades in the USA [PDF]
Endocrine Connections, 2023 Background: Updated epidemiological data of neuroendocrine tumors are currently lacking. Thus, we performed epidemiological and survival analyses on a large cohort of patients with neuroendocrine tumors and developed a new nomogram to predict survival.
Peiwen Wu +3 more
doaj +2 more sources
NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
Endocrine Connections, 2022 Objective: Up to now, serial NETest measurements in individuals assessing the disease course of gastroenteropancreatic neuroendocrine tumors (GEPNETs) at long-term follow-up and treatment response were not studied.
Mark J C van Treijen +4 more
doaj +1 more source
Neuroendocrine Tumor of the Gallbladder [PDF]
Polish Journal of Radiology, 2015 The primary neuroendocrine tumors of the gallbladder are very rare, representing 0.2% of all neuroendocrine tumors. The definite diagnosis is incidental in most cases.A 60-year-old male patient presented with a one-month history of epigastric pain and jaundice, itching, flushing, cough and wheezing.
Monier, Ahmed +4 more
openaire +3 more sources
BMC Gastroenterology, 2020 Background NETest, a novel multi-gene liquid biopsy has utility in neuroendocrine tumor (NET) diagnosis and identification of residual disease. We independently assessed utility of the NETest to diagnose gastric neuroendocrine neoplasms (GNENs) and ...
A. Malczewska +6 more
doaj +1 more source
The influence of surgery quality on the longtime results of gastric cancer combination therapy
Nowotwory, 2022 INTRODUCTION: The aim of this study was to analyze the influence of surgical center experience on the long term survival of patients with locoregionally advanced gastric adenocarcinoma undergoing primary surgery, followed by complementary ...
Ireneusz Pierzankowski +4 more
doaj +1 more source
Risk of malignancy in adrenal tumors in patients with a history of cancer
Frontiers in Oncology, 2023 PurposeAdrenal gland is a common site of metastasis and on the other hand, metastases are the most frequent malignant adrenal tumors. The aim of this study was to estimate the risk of malignancy in suspicious adrenal mass in patients with a history of ...
Radosław Samsel +11 more
doaj +1 more source
Duodenal carcinoid tumour – a case report [PDF]
, 2020 Duodenal carcinoids are rare tumours of the small intestine with heterogenous clinical and pathological characteristics. The long-term prognosis is very good if discovered in the early stages.
Alexescu, Teodora Gabriela +7 more
core +2 more sources
Updates on medical treatment for neuroendocrine neoplasm [PDF]
Zhongguo aizheng zazhi, 2022 Neuroendocrine neoplasm (NEN) is a group of heterogeneous malignancies arising from neuroendocrine cells and peptidergic neurons. According to its cell differentiation, NEN can be divided into two distinct groups as well-differentiated neuroendocrine ...
LIANG Yun, JI Shunrong, YU Xianjun, CHEN Jie
doaj +1 more source
Fishing for neuroendocrine tumors [PDF]
Endocrine-Related Cancer, 2020 Neuroendocrine tumors (NETs) are a class of rare and heterogeneous neoplasms that originate from the neuroendocrine system. In several cases, these neoplasms can release bioactive hormones leading to characteristic clinical syndromes and hormonal dysregulations with detrimental impact on the quality of life and survival of these patients.
Gaudenzi G. +5 more
openaire +2 more sources
Updates on precision medicine of pancreatic neuroendocrine tumor [PDF]
Zhongguo aizheng zazhi, 2023 Since the concept of precision medicine proposed in 2011, the treatment of solid tumors has entered era of precision medicine led by gene testing. As a rare tumor, the incidence rate of pancreatic neuroendocrine tumor (PanNET) is increasing gradually. In
GAO Heli, XU Jin, CHEN Jie, YU Xianjun
doaj +1 more source